Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 194723, 7 pages
http://dx.doi.org/10.1155/2012/194723
Research Article

Involvement of the Ubiquitin-Proteasome System in the Formation of Experimental Postsurgical Peritoneal Adhesions

1Department of Experimental Medicine, Section of Pharmacology “L. Donatelli”, Second University of Naples, 80138 Naples, Italy
2Department of Gerontology, Geriatric and Metabolic Diseases, Second University of Naples, 80138 Naples, Italy

Received 26 July 2011; Revised 31 October 2011; Accepted 5 November 2011

Academic Editor: Wolfgang Neuhofer

Copyright © 2012 Clara Di Filippo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Canis, R. Botchorishvili, A. Wattiez et al., “Prevention of peritoneal adherences,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 30, no. 4, pp. 305–324, 2001. View at Google Scholar
  2. J. A. P. Attard and A. R. Maclean, “Adhesive small bowel obstruction: epidemiology, biology and prevention,” Canadian Journal of Surgery, vol. 50, no. 4, pp. 291–300, 2007. View at Google Scholar · View at Scopus
  3. D. E. Ott, “Laparoscopy and adhesion formation, adhesions and laparoscopy,” Seminars in Reproductive Medicine, vol. 26, no. 4, pp. 322–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Di Filippo, A. Falsetto, V. De Pascale et al., “Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesions,” Mediators of Inflammation, vol. 2006, Article ID 13901, 4 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. I. W. Lauder, G. Garcea, A. Strickland, and G. J. Maddern, “Abdominal adhesion prevention: still a sticky subject?” Digestive Surgery, vol. 27, no. 5, pp. 347–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Schnriger, G. Barmparas, B. C. Branco, T. Lustenberger, K. Inaba, and D. Demetriades, “Prevention of postoperative peritoneal adhesions: a review of the literature,” American Journal of Surgery, vol. 201, no. 1, pp. 111–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Holmdahl and M. L. Ivarsson, “The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair,” European Journal of Surgery, vol. 165, no. 11, pp. 1012–1019, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Suzuki and A. Imai, “HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A,” Journal of Obstetrics and Gynaecology, vol. 30, no. 4, pp. 404–407, 2010. View at Publisher · View at Google Scholar
  9. L. Tietze, A. Elbrecht, C. Schauerte et al., “Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor β1 (TGF-β1), tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β),” Thrombosis and Haemostasis, vol. 79, no. 2, pp. 362–370, 1998. View at Google Scholar
  10. A. Aykas, M. F. Yuzbasioglu, E. B. Kurutas et al., “Protective effects of propofol on peritoneal adhesions in cecal ligation and puncture model,” Bratislavské Lekárske Listy, vol. 111, no. 5, pp. 253–257, 2010. View at Google Scholar · View at Scopus
  11. R. Marfella, C. D. Filippo, M. Portoghese et al., “The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control,” Cardiovascular Pathology, vol. 18, no. 6, pp. 332–345, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Di Filippo, R. Marfella, and M. D'Amico, “Possible dual role of ubiquitin-proteasome system in the atherosclerotic plaque progression,” Journal of the American College of Cardiology, vol. 52, no. 16, pp. 1350–1351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Marfella, M. D'Amico, K. Esposito et al., “The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment,” Diabetes, vol. 55, no. 3, pp. 622–632, 2006. View at Google Scholar · View at Scopus
  14. R. Marfella, C. D. Filippo, M. Portoghese et al., “The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control,” Cardiovascular Pathology, vol. 18, no. 6, pp. 332–345, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Van Herck, G. R. Y. De Meyer, W. Martinet, H. Bult, C. J. Vrints, and A. G. Herman, “Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice,” Basic Research in Cardiology, vol. 105, no. 1, pp. 39–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. G. Eldridge and T. O'Brien, “Therapeutic strategies within the ubiquitin proteasome system,” Cell Death and Differentiation, vol. 17, no. 1, pp. 4–13, 2010. View at Google Scholar · View at Scopus
  17. M. Yamamura, T. Hirai, and Y. Yamaguchi, “Proteasome inhibitor,” Nippon Rinsho, vol. 68, no. 6, pp. 1079–1084, 2010. View at Google Scholar · View at Scopus
  18. J. D. Etlinger and A. L. Goldberg, “A soluble ATP dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 1, pp. 54–58, 1977. View at Google Scholar · View at Scopus
  19. A. Ciechanover, H. Heller, S. Elias, A. L. Haas, and A. Hershko, “ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 3, pp. 1365–1368, 1980. View at Google Scholar · View at Scopus
  20. A. Hershko, A. Ciechanover, H. Heller, A. L. Haas, and I. A. Rose, “Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 4, pp. 1783–1786, 1980. View at Google Scholar · View at Scopus
  21. B. A. Schulman and J. Wade Harper, “Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways,” Nature Reviews Molecular Cell Biology, vol. 10, no. 5, pp. 319–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Ye and M. Rape, “Building ubiquitin chains: E2 enzymes at work,” Nature Reviews Molecular Cell Biology, vol. 10, no. 11, pp. 755–764, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Robinson and H. C. Ardley, “Ubiquitin-protein ligases,” Journal of Cell Science, vol. 117, no. 22, pp. 5191–5194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Voges, P. Zwickl, and W. Baumeister, “The 26S proteasome: a molecular machine designed for controlled proteolysis,” Annual Review of Biochemistry, vol. 68, pp. 1015–1068, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. P. H. Stone, J. E. Muller, T. Hartwell et al., “The effect of diabetes mellitus on prognosis and serial left ventricular function after myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis,” Journal of the American College of Cardiology, vol. 14, no. 1, pp. 49–57, 1989. View at Google Scholar · View at Scopus
  26. A. Hershko, A. Ciechanover, and A. Varshavsky, “Basic medical research award. The ubiquitin system,” Nature Medicine, vol. 6, no. 10, pp. 1073–1081, 2000. View at Publisher · View at Google Scholar
  27. S. Frank, O. Seitz, C. Schürmann et al., “Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: a comparative study,” Experimental Diabetes Research, vol. 2010, Article ID 476969, 15 pages, 2010. View at Publisher · View at Google Scholar
  28. F. A. Hanzu, M. Palomo, S. G. Kalko et al., “Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses,” Journal of Thrombosis and Haemostasis, vol. 9, no. 6, pp. 1236–1245, 2011. View at Publisher · View at Google Scholar
  29. G. Kirovski, A. P. Stevens, B. Czech et al., “Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5′-deoxy- 5′-methylthioadenosine (MTA),” American Journal of Pathology, vol. 178, no. 3, pp. 1145–1152, 2011. View at Publisher · View at Google Scholar
  30. V. J. Palombella, O. J. Rando, A. L. Goldberg, and T. Maniatis, “The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB,” Cell, vol. 78, no. 5, pp. 773–785, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. U. Siebenlist, G. Franzoso, and K. Brown, “Structure, regulation and function of NF-κB,” Annual Review of Cell Biology, vol. 10, pp. 405–455, 1994. View at Google Scholar · View at Scopus
  32. J. Hermann, R. Gulati, C. Napoli et al., “Oxidative stress-related increase in ubiquitination in early coronary atherogenesis,” The FASEB Journal, vol. 17, no. 12, pp. 1730–1732, 2003. View at Google Scholar · View at Scopus
  33. J. Herrmann, A. Ciechanover, L. O. Lerman, and A. Lerman, “The ubiquitin-proteasome system in cardiovascular diseases—a hypothesis extended,” Cardiovascular Research, vol. 61, no. 1, pp. 11–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sun, F. Dawood, W. H. Wen et al., “Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction,” Circulation, vol. 110, no. 20, pp. 3221–3228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Adams, V. J. Palombella, E. A. Sausville et al., “Proteasome inhibitors: a novel class of potent and effective antitumor agents,” Cancer Research, vol. 59, no. 11, pp. 2615–2622, 1999. View at Google Scholar · View at Scopus
  36. L. J. Crawford, B. Walker, and A. E. Irvine, “Proteasome inhibitors in cancer therapy,” Journal of Cell Communication and Signaling, vol. 5, no. 2, pp. 101–110, 2011. View at Publisher · View at Google Scholar